Susquehanna International Group
BRLI

Susquehanna International Group’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Susquehanna International Group’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-41,817
Closed -$1.73M – 10868
2015
Q2 		$1.73M Buy
+41,817
New +$1.5M ﹤0.01% 5031
2015
Q1 		– Sell
-151,785
Closed -$5.14M – 10468
2014
Q4 		$4.88M Sell
151,785
-24,119
-14% -$698K ﹤0.01% 2928
2014
Q3 		$4.94M Buy
175,904
+4,996
+3% +$152K ﹤0.01% 3042
2014
Q2 		$5.17M Buy
170,908
+35,226
+26% +$972K ﹤0.01% 3020
2014
Q1 		$3.76M Buy
135,682
+35,194
+35% +$921K ﹤0.01% 3305
2013
Q4 		$2.57M Buy
+100,488
New +$3.1M ﹤0.01% 3869

Other funds holding BRLI

SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Susquehanna International Group's BRLI Position: Q3 2015 in Review

Susquehanna International Group sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 41,817 shares — an estimated $1.73M sold.

Susquehanna International Group first reported a position in BRLI in Q4 2013 and held it in 6 quarters. The position peaked at $5.17M in Q2 2014. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

  • Susquehanna International Group reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
  • Susquehanna International Group sold 41,817 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $1.73M.
  • Susquehanna International Group first reported a position in BIO-REFERENCE LABS INC-NEW- in Q4 2013 and held it in 6 quarters.
  • Susquehanna International Group's BIO-REFERENCE LABS INC-NEW- position peaked at $5.17M in Q2 2014.
  • 1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Susquehanna International Group's 13F filing for Q3 2015, filed 16 Nov 2015.